These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 14282070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ISOLATION AND PROPERTIES OF ANTICOAGULANTS FROM FIBRINOLYSED AND HUMAN HEART-PUMP PLASMAS.
    TRIANTAPHYLLOPOULOS DC, TRIANTAPHYLLOPOULOS E.
    Can J Physiol Pharmacol; 1964 Mar; 42():169-87. PubMed ID: 14329312
    [No Abstract] [Full Text] [Related]

  • 5. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E, BUDZYNSKI AZ, KOPEC M, LATALLO ZS, LIPINSKI B, WEGRZYNOWICZ Z.
    Thromb Diath Haemorrh; 1964 Oct 15; 12():69-86. PubMed ID: 14224647
    [No Abstract] [Full Text] [Related]

  • 6. A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
    MAKI M, KIKUCHI K, WATANABE S, KIKUCHI E.
    Tohoku J Exp Med; 1964 Dec 25; 84():274-81. PubMed ID: 14244484
    [No Abstract] [Full Text] [Related]

  • 7. Variable and invarible components of the anticoagulant fraction of incubated fibrinogen.
    Triantaphyllopoulos E, Triantaphyllopoulos DC.
    Nature; 1966 Jan 15; 209(5020):265-7. PubMed ID: 5915958
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H.
    Kobe J Med Sci; 1963 Dec 15; 18():169-77. PubMed ID: 14160537
    [No Abstract] [Full Text] [Related]

  • 11. THE FORMATION OF CHONDROMUCOPROTEIN-FIBRINOGEN AND CHONDROMUCOPROTEIN-BETA-LIPOPROTEIN COMPLEXES.
    ANDERSON AJ.
    Biochem J; 1963 Sep 15; 88(3):460-9. PubMed ID: 14071519
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW, NILSSON IM.
    Acta Physiol Scand; 1964 Mar 15; 60():267-77. PubMed ID: 14131840
    [No Abstract] [Full Text] [Related]

  • 16. [EXPERIMENT WITH A PLASMIN PREPARATION BY USING THE CASIN SPLITTING TEST: THE ACTION OF PLASMIN-NOVO AND ITS INHIBITION WITH EPSILON-AMINOCAPROIC ACID AND TRASYLOL].
    BERGHOFF A, GLATZEL H.
    Thromb Diath Haemorrh; 1964 Dec 31; 12():418-24. PubMed ID: 14254701
    [No Abstract] [Full Text] [Related]

  • 17. THE ROLE OF FIBRINOLYSIN AND PROFIBRINOLYSIN ACTIVATOR IN HEMOPHILIA.
    REID WO, HOLBURN RR, DESIPIN MT, TOCANTINS LM.
    Am J Med Sci; 1965 May 31; 249():518-33. PubMed ID: 14280891
    [No Abstract] [Full Text] [Related]

  • 18. THROMBOLYTIC THERAPY.
    DOUGLAS AS, MCNICOL GP.
    Br Med Bull; 1964 Sep 31; 20():228-32. PubMed ID: 14209763
    [No Abstract] [Full Text] [Related]

  • 19. STUDIES ON THE TISSUE ACTIVATOR OF PLASMINOGEN. DISTRIBUTION OF ACTIVATOR AND PROTEOLYTIC ACTIVITY IN THE SUBCELLULAR FRACTIONS OF RABBIT KIDNEY.
    ALI SY, LACK CH.
    Biochem J; 1965 Jul 31; 96(1):63-74. PubMed ID: 14343153
    [Abstract] [Full Text] [Related]

  • 20. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F, KLOECKING HP, RICHTER M.
    Acta Biol Med Ger; 1964 Jul 31; 12():522-4. PubMed ID: 14134957
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.